TETTAMANTI, SARAH
 Distribuzione geografica
Continente #
NA - Nord America 1.658
EU - Europa 1.091
AS - Asia 438
SA - Sud America 9
OC - Oceania 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.202
Nazione #
US - Stati Uniti d'America 1.642
IT - Italia 415
IE - Irlanda 195
CN - Cina 148
DE - Germania 144
SG - Singapore 132
SE - Svezia 109
RU - Federazione Russa 78
HK - Hong Kong 51
GB - Regno Unito 40
IN - India 35
FI - Finlandia 18
CA - Canada 16
UA - Ucraina 15
ID - Indonesia 14
BE - Belgio 13
PK - Pakistan 13
DK - Danimarca 12
VN - Vietnam 12
JP - Giappone 10
FR - Francia 9
RO - Romania 8
NL - Olanda 7
AT - Austria 6
TR - Turchia 6
TW - Taiwan 5
BR - Brasile 4
CH - Svizzera 4
NO - Norvegia 4
RS - Serbia 4
AU - Australia 3
CZ - Repubblica Ceca 3
ES - Italia 3
IR - Iran 3
BD - Bangladesh 2
BO - Bolivia 2
IL - Israele 2
KR - Corea 2
PE - Perù 2
PL - Polonia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CO - Colombia 1
LT - Lituania 1
MA - Marocco 1
MY - Malesia 1
ZA - Sudafrica 1
Totale 3.202
Città #
Ann Arbor 429
Chandler 196
Dublin 189
Milan 119
Singapore 115
Fairfield 114
Frankfurt am Main 105
Ashburn 95
Wilmington 78
Seattle 74
Woodbridge 62
New York 58
Houston 51
Hong Kong 49
Cambridge 47
Shanghai 47
Princeton 39
Bergamo 34
Dearborn 28
Lissone 22
Nanjing 21
Santa Clara 18
Altamura 17
Jakarta 14
Lawrence 14
Brussels 13
Borgomanero 12
Carrboro 11
Jacksonville 11
Monza 11
Carate Brianza 10
Dallas 10
Helsinki 10
Hyderabad 10
Chicago 9
Andover 8
Fremont 8
Galliate 8
Rome 8
Tokyo 8
Hangzhou 7
London 7
Beijing 6
Lahore 6
Missaglia 6
Munich 6
Cinisello Balsamo 5
Contursi 5
Edmonton 5
Islamabad 5
Jinan 5
Lappeenranta 5
Naples 5
Pioltello 5
Pune 5
Toronto 5
Turin 5
Vienna 5
Bologna 4
Caronno Pertusella 4
Genoa 4
Ottawa 4
San Diego 4
Zhengzhou 4
Amstelveen 3
Bergen 3
Boardman 3
Brescia 3
Brno 3
Castano Primo 3
Cerreto Guidi 3
Delhi 3
Desio 3
Durham 3
Florence 3
Guangzhou 3
Kocaeli 3
Legnano 3
Manchester 3
Muggiò 3
Mumbai 3
Nanchang 3
New Taipei 3
Pavia 3
Perugia 3
Stockholm 3
Torino 3
Washington 3
Bari 2
Borca 2
Boston 2
Bucharest 2
Carate 2
Catania 2
Changsha 2
Charlottesville 2
Chengdu 2
Dhaka 2
Dong Ket 2
Forlì 2
Totale 2.400
Nome #
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 288
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 261
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 239
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 234
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 233
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 225
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 193
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA 138
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 129
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 127
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies 116
Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia 115
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden 107
Catch me if you can: how AML and its niche escape immunotherapy 99
Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use 95
Cellule CD33.CAR-CIK ingegnerizzate per co-esprimere il recettore CXCR4 al fine di aumentare la capacità di migrazione all’interno della nicchia midollare nella leucemia mieloide acuta 94
Generation of CIK cells co-expressing CXCR4 and CD33.CAR with improved homing and antitumor activity for AML 88
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden 81
CXCR4-modified CD33.CAR-CIK with enhanced bone marrow homing in Acute Myeloid Leukemia 80
Combining the expression of CD33.CAR and CXCR4 to augment CAR-CIKs homing to bone marrow niche and leukemic stem cell eradication in acute myeloid leukemia 80
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 56
CARs are sharpening their weapons 55
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche 53
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia 53
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia 45
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare 44
Acute Myeloid Leukemia (AML) immunotherapy: development of TIM3-CD33 targeted Dual CAR CIK cells for eradication of LSCs in the bone marrow niche 35
Totale 3.363
Categoria #
all - tutte 12.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.434


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020235 0 0 0 28 30 44 48 20 20 11 12 22
2020/2021627 20 72 136 55 51 62 39 46 33 43 29 41
2021/2022340 23 33 22 18 20 18 11 15 24 32 24 100
2022/2023737 102 174 70 66 17 97 19 53 51 4 60 24
2023/2024747 32 30 45 61 72 181 123 47 61 19 14 62
2024/2025367 65 111 148 43 0 0 0 0 0 0 0 0
Totale 3.363